A US cannabis brand-centric company is set to launch on the public markets in Canada through a reverse takeover (RTO) of a Canadian-based company.

Denver-based Dixie Brands announced on Monday (October 1) that it has completed a merger with a public shell corporation, Academy Explorations, to perform an RTO and gain a listing on the Canadian Securities Exchange (CSE) — a favorite destination for US pot companies.

Following the RTO, the company will be renamed to Dixie Brands (USA).

“By going public on the CSE, we’re investing in Dixie’s future for continued growth with a focus on quality, product innovation and scale,” Chuck Smith, CEO of Dixie Brands, said in a press release. Dixie will have to wait for approval from the CSE to list.

Documents from Academy Explorations show because Dixie raised a higher amount of capital through its Series C round of funding, the shell company expects “the exchange ratio applicable to shares, options and warrants under the Agreement will be higher than previously disclosed.”

Due to its laxed restrictions on US operations, the CSE has become the go-to exchange for companies operating assets in the US looking to capitalize on the rush for cannabis stocks seen in Canada.

Barrington Miller, director of listed company services for the CSE, told the Investing News Network (INN) the CSE made an early call to not block the listing of non licensed producer (LP) cannabis ventures.

US cannabis companies are able to join the CSE as the exchange only requests a risk disclosure each month for investors.

As cannabis remains an illegal substance on the federal level in the US, no company operating below the border has been able to join senior markets like the Toronto Stock Exchange (TSX).

Dixie currently operates in the states of Colorado, California, Nevada and Maryland. The company also disclosed it expects to have a presence in four-to-six new states in 2019.

To support this expansion, the company completed a series C funding which resulted in nearly US$25 million raised. Dixie indicated “positive investor demand” raised its original target of US$20 million for the funding.

With the Canadian listing, Dixie announced its intention to expand its business into Canada as well. “The financing round we have just closed will provide resources for Dixie to expand our brand throughout the US and into Canada,” Smith said.

Dixie touts its flagship product being an infused beverage with tetrahydrocannabinol (THC) called the Dixie Elixir. However, its entire portfolio shows a wide range of edibles such as infused chocolates, mints, gummies and tarts.

Infused beverages have become a novelty investment from cannabis companies in Canada and have even led to speculation about partnerships between producers and large players such as Diageo (NYSE:DEO) and The Coca-Cola Company (NYSE:KO).

Edible products will not become legal starting with the adult-use legalization in Canada on October 17. Health Canada, the country’s federal government arm tasked with regulating the use of the drug for consumers, has said these novel products will take a year after legalization to be approved.

A study from research firm the Marijuana Policy Group, and the University of Colorado Boulder, Leeds School of Business, business research division, found infused edibles in the state of Denver represented 4.9 percent of the cannabis product sold in Colorado in 2017.

Investor takeaway

As the growing sentiment on cannabis legalization continues more US companies look to Canada for new ways to raise money and fund operations.

Dixie’s additional announcement of pursuing the Canadian market marks an interesting direct approach from a US brand.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less